Time‐varying covariates, overadjustment bias and mediation in pharmacokinetic/pharmacodynamic modeling by Sebastiaan Camiel Goulooze, Nelleke Snelder

Connect to this object online.

Quantification of the effect of GLP‐1R agonists on body weight using in vitro efficacy information: An extension of the Hall body composition model by Rolien Bosch, Eric J. G. Sijbrands, Nelleke Snelder

Connect to this object online.

A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP‐1 dual agonist by Rolien Bosch, Marcella Petrone, Rosalin Arends, Paolo Vicini, Eric J. G. Sijbrands, Sven Hoefman, Nelleke Snelder

Connect to this object online.

Evaluation of a Cardiovascular Systems Model for Design and Analysis of Hemodynamic Safety Studies by Yu Fu, Nelleke Snelder, Tingjie Guo, Piet H. van der Graaf, Johan. G. C. van Hasselt

Connect to this object online.

Navigating the landscape of parameter identifiability methods: A workflow recommendation for model development by Martijn vanNoort, Martijn Ruppert, Joost DeJongh, Eleonora Marostica, Rolien Bosch, Emir Mešić, Nelleke Snelder

Connect to this object online.

A novel cardiovascular systems model to quantify drugs effects on the inter‐relationship between contractility and other hemodynamic variables by Yu Fu, Hadi Taghvafard, Medhat M. Said, Eric I. Rossman, Teresa A. Collins, Stéphanie Billiald‐Desquand, Derek Leishman, Piet H. van derGraaf, J. G. Coen vanHasselt, Nelleke Snelder

Connect to this object online.

PK/PD modeling of FXI antisense oligonucleotides to bridge the dose‐FXI activity relation from healthy volunteers to end‐stage renal disease patients by Stefan Willmann, Eleonora Marostica, Nelleke Snelder, Alexander Solms, Markus Jensen, Maximilian Lobmeyer, Anthonie W. A. Lensing, Claudette Bethune, Erin Morgan, Rosie Z. Yu, Yanfeng Wang, Shiangtung W. Jung, Richard Geary, Sanjay Bhanot

Connect to this object online.